Persistent unilateral facial nerve deficit in children
Stable but persistent unilateral facial weakness present at 18 months should be treated as nonresolving facial nerve palsy and should prompt reassessment for an underlying cause plus long-term facial nerve and eye sequelae risk reduction. (ncbi.nlm.nih.gov) This evaluation should include a careful re-examination for progression or new neurologic deficits, targeted otologic and skin findings, and a determination of whether the presentation is consistent with idiopathic facial nerve palsy versus atypical or secondary etiologies. (ncbi.nlm.nih.gov) If the cause remains unclear after clinical assessment, imaging and selected laboratory testing are recommended. (ncbi.nlm.nih.gov)
Etiology-focused clinical reassessment
A detailed history should document onset timing, maximum severity, interval change, exposure risks, and associated symptoms such as otalgia, vesicular rash, hearing loss, or systemic symptoms. (ncbi.nlm.nih.gov) A focused head and neck examination should document the distribution of facial weakness, synkinesis, facial asymmetry, and ocular protection risk including incomplete eyelid closure and corneal sensation. (ncbi.nlm.nih.gov) Skin and ear examination should evaluate for vesicles consistent with Ramsay Hunt syndrome, parotid swelling, lymphadenopathy, and infectious or inflammatory clues that could change etiology assessment. (ncbi.nlm.nih.gov)
Medication selection algorithm
No empiric corticosteroid or antiviral therapy is recommended as a default treatment at 18 months of stable deficit without evidence of an active, treatable infectious or inflammatory process. (ncbi.nlm.nih.gov) When Lyme disease is suspected based on exposure risk and neurologic cranial nerve involvement, antibiotic management should follow Lyme disease guidance for the relevant clinical presentation. (idsociety.org)
Diagnostic evaluation strategy
Imaging is recommended when the cause of facial paralysis remains unclear after thorough history and physical examination. (ncbi.nlm.nih.gov) Contrast-enhanced CT of the parotid bed and temporal bone is recommended first in this diagnostic sequence. (ncbi.nlm.nih.gov) MRI of the brain and internal auditory canal is recommended if CT is negative in the diagnostic sequence. (ncbi.nlm.nih.gov) Electrodiagnostic testing can be used to assess injury location and severity when needed, including electroneuronography and EMG. (ncbi.nlm.nih.gov) Laboratory testing for specific etiologies is recommended when clinical suspicion persists despite negative or non-diagnostic imaging, including pathogens such as Lyme, HSV-1, CMV, EBV, and VZV when supported by the differential. (ncbi.nlm.nih.gov)
Monotherapy versus combination therapy
Antibiotic therapy is recommended as monotherapy for Lyme disease when Lyme disease is the suspected etiology of facial nerve palsy, with regimen selection based on the guideline-recommended Lyme presentation and severity. (idsociety.org) Combination therapy with corticosteroids plus antibiotics is not recommended as a general strategy specifically for Lyme disease–associated facial nerve palsy because corticosteroid use is addressed as not having a guideline recommendation to add corticosteroids to antibiotics for Lyme facial nerve palsy. (idsociety.org)
Important clarifications for nonresolving palsy
A stable deficit at 18 months falls outside the typical spontaneous recovery window for idiopathic Bell palsy and therefore should not be managed as a self-limited idiopathic process. (healthychildren.org) When paresis has plateaued or remains complete, electrodiagnostic testing and cross-sectional imaging are used to guide further evaluation for structural or demyelinating injury and to rule out secondary causes. (ncbi.nlm.nih.gov) If imaging identifies tumor or other structural pathology along the facial nerve course, management should shift to etiology-directed treatment rather than facial nerve supportive care alone. (ncbi.nlm.nih.gov)
Initiation thresholds and referral triggers
ENT (otolaryngology) and neurology referral is recommended for persistent nonresolving unilateral facial nerve palsy when the etiology is not established. (ncbi.nlm.nih.gov) Urgent referral is indicated when facial weakness is accompanied by ocular exposure risk such as incomplete eyelid closure or corneal sensation impairment, because protective interventions may be required to prevent corneal injury. (ncbi.nlm.nih.gov) Lyme disease evaluation should be initiated when cranial nerve palsy occurs and there is clinical concern for Lyme exposure, with management requiring specialist discussion for presentations other than uncomplicated erythema migrans. (nice.org.uk)
Common pitfalls to avoid
Ocular protection planning should not be delayed in a child with persistent unilateral facial weakness because incomplete closure and corneal exposure risk are clinically assessed and can require intervention. (ncbi.nlm.nih.gov) Imaging should not be omitted when the cause remains unclear after systematic clinical evaluation, because the recommended workup includes contrast-enhanced CT followed by MRI when CT is negative. (ncbi.nlm.nih.gov) Assuming idiopathic Bell palsy without re-evaluating for atypical features is a risk for missed secondary etiologies when recovery fails to occur. (ncbi.nlm.nih.gov)
Targets and goals of therapy
The goals for persistent unilateral facial nerve palsy include preventing ocular complications, documenting neurologic stability, and identifying reversible etiologies through imaging and selected testing. (ncbi.nlm.nih.gov) Functional assessment and injury severity assessment using electrodiagnostic studies can be used to track nerve injury status when recovery remains incomplete. (ncbi.nlm.nih.gov) Etiology-directed treatment is the target when imaging or laboratory testing identifies a treatable cause such as Lyme disease. (idsociety.org)